Instadose Pharma Corp.

Instadose Pharma Corp. is a holding company focused on the global medicinal cannabis and cannabinoid oil sector. Its primary activity centers on developing and managing a large-scale distribution platform for medical-grade cannabis and cannabinoid oil, aiming to supply pharmaceutical companies with high-quality, sustainable, and cost-effective ingredients for pharmaceutical use. Instadose Pharma Corp., through its wholly owned subsidiary Instadose Canada, operates across five continents—Africa, Europe, Asia, South America, and North America—by establishing operational subsidiaries and joint ventures to secure government-issued licenses and facilitate legal cultivation and distribution. The company’s platform is designed to coordinate the transport, sale, and sourcing of medicinal cannabis and cannabinoid oil, connecting cultivation and production participants with the global pharmaceutical industry. By leveraging an expansive international footprint, Instadose Pharma Corp. plays a key role in the emerging medicinal cannabis supply chain, with ambitions to broaden access and streamline the movement of pharmaceutical-grade cannabis products worldwide.